What Are The Chances Of Sarepta Therapeutics Inc (NASDAQ: SRPT) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

As a NASDAQ listed company, SRPT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Sarepta Therapeutics Inc is $14.11B. A total of 0.83 million shares were traded on the day, compared to an average of 1.82M shares.

In the most recent transaction, Brown Ryan Edward sold 38,957 shares of SRPT for 161.61 per share on Jun 25 ’24. After the transaction, the EVP, General Counsel now owns 17,129 company shares. In a previous transaction on Jun 25 ’24, Arif Bilal sold 3,898 shares at 163.23 per share. SRPT shares that Chief Tech Ops Officer owns now total 17,363.

Among the insiders who sold shares, Arif Bilal disposed of 7,859 shares on Jun 24 ’24 at a per-share price of $163.08. This resulted in the Chief Tech Ops Officer holding 21,261 shares of SRPT after the transaction. In another insider transaction, Murray Dallan sold 3,635 shares at $140.00 per share on May 02 ’24. Company shares held by the Chief Customer Officer now total 18,125.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SRPT has a high of $173.25 and a low of $55.25.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $10.17, while its Total Shareholder’s Equity was $928.01M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.53.

Most Popular

Related Posts